Novartis Corporation Political Action Committee FEB MONTHLY Filings
Cycle | Date Filed | End Date | Amendment | Receipts | Spending | Cash |
---|---|---|---|---|---|---|
2024 | Feb. 15 | Jan. 31 | $17,011.15 | $100.91 | $141,826.17 | |
2024 | Feb. 17, 2023 | Jan. 31, 2023 | $16,626.77 | $5.38 | $168,267.01 | |
2022 | Feb. 17, 2022 | Jan. 31, 2022 | $17,418.43 | $0.00 | $207,692.71 | |
2022 | Feb. 17, 2021 | Jan. 31, 2021 | $16,901.04 | $390.57 | $171,654.56 | |
2020 | Feb. 18, 2020 | Jan. 31, 2020 | $26,860.91 | $10,515.13 | $123,286.93 | |
2020 | Aug. 13, 2019 | Jan. 31, 2019 | Compare to original | $20,490.80 | $11,012.68 | $114,646.74 |
2018 | Feb. 16, 2018 | Jan. 31, 2018 | $17,876.58 | $27,015.04 | $106,845.72 | |
2018 | May 19, 2017 | Jan. 31, 2017 | Compare to original | $16,571.13 | $21,016.20 | $77,876.22 |
2016 | Feb. 19, 2016 | Jan. 31, 2016 | $16,540.30 | $53,096.93 | $114,594.91 | |
2016 | Feb. 18, 2015 | Jan. 31, 2015 | $21,733.94 | $75,622.13 | $139,951.43 | |
2014 | Feb. 20, 2014 | Jan. 31, 2014 | $24,152.74 | $83,543.62 | $139,338.66 | |
2014 | Feb. 20, 2013 | Jan. 31, 2013 | $20,299.98 | $98,085.79 | $125,014.58 | |
2012 | Feb. 17, 2012 | Jan. 31, 2012 | $28,801.01 | $80,080.00 | $165,828.28 | |
2012 | Feb. 18, 2011 | Jan. 31, 2011 | $29,078.43 | $60,970.00 | $100,752.50 | |
2010 | Feb. 19, 2010 | Jan. 31, 2010 | $30,796.03 | $75,220.00 | $80,200.51 | |
2010 | Feb. 19, 2009 | Jan. 31, 2009 | $25,888.93 | $15,100.00 | $149,660.24 | |
2008 | April 17, 2008 | Jan. 31, 2008 | Compare to original | $30,038.30 | $44,600.00 | $154,130.00 |
2008 | Feb. 16, 2007 | Jan. 31, 2007 | $27,680.50 | $38,500.00 | $81,572.60 | |
2006 | Feb. 15, 2006 | Jan. 31, 2006 | $22,009.40 | View | $67,364.00 | |
2006 | Feb. 18, 2005 | Jan. 31, 2005 | $19,501.50 | $1,500.00 | $68,078.10 | |
2004 | Feb. 17, 2004 | Jan. 31, 2004 | $20,644.20 | $22,000.00 | $81,546.70 | |
2004 | Feb. 13, 2003 | Jan. 31, 2003 | View | View | ||
2002 | April 17, 2002 | Jan. 31, 2002 | View | View | ||
2002 | Feb. 20, 2001 | Jan. 31, 2001 | View | View |